 |
Minimale Einzahlung $50 Exklusive Aktion |
Unser Ergebnis |
0% Kommission |
Are you looking to buy Synthetic Biologics stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:SYN! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Synthetic Biologics stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Synthetic Biologics, Inc., a clinical-stage company develops therapeutics to treat gastrointestinal diseases in the United States. Its lead product candidates include SYN-004 that has completed Phase II clinical trial designed to degrade commonly used intravenous beta-lactam antibiotics in gastrointestinal tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), and acute graft-versus-host-disease in allogeneic hematopoietic cell transplant recipients. The company is also developing SYN-010 that is in Phase IIb/III clinical trial to reduce the impact of methane-producing organisms in the gut microbiome to treat an underlying cause of irritable bowel syndrome with constipation; and SYN-020, an early-stage oral formulation for the enzyme intestinal alkaline phosphatase to treat both local GI and systemic diseases. In addition, its clinical stage products include SYN-006 and SYN-007 for the prevention of CDI, overgrowth of pathogenic organisms, and AMR; and SYN-005 for the prevention and treatment of pertussis. Synthetic Biologics, Inc. has collaborations with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center; and a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. The company is headquartered in Rockville, Maryland.
Durchschnittliches Volumen
31.49 million shs
MARKTKAPPE
$19.99 million
Börse
NYSEAMERICAN
Kaufen Sie diese Aktie!
|
NAME
|
TICKER
|
INDUSTRIE
|
SECTOR
|
VOLUME
|
KAUFEN SIE DIESE AKTIE JETZT
|
|---|---|---|---|---|---|
|
AMEX:SYN
|
Pharmazeutische Präparate
|
Medizinisch
|
317,349 shs
|
Below is a quick guide on how to buy AMEX:SYN stocks safe, fast and around the world in less than five minutes.
Schritt 1: Eröffnen Sie ein Konto bei eToro – eToro is the best broker to buy Synthetic Biologics shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Schritt 2: Laden Sie Ihre ID hoch - Gemäß den KYC-Vorschriften wird eToro Sie bitten, eine Kopie Ihres Reisepasses oder Führerscheins hochzuladen.
Schritt 3: Geld einzahlen - Zahlen Sie etwas Geld auf Ihr neu eingerichtetes eToro Konto ein. Sie können zwischen Banküberweisung, E-Wallet, Debit-/Kreditkarte oder Paypal wählen.
Schritt 4: Buy Synthetic Biologics – Search for “”AMEX:SYN”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Synthetic Biologics stocks with 0% commission!.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
2 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Synthetic Biologics in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” Synthetic Biologics stock.
Wall Street analysts have given Synthetic Biologics a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but Synthetic Biologics wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
2 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
3 |  | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:SYN stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Synthetic Biologics stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Synthetic Biologics stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Da es sich bei eToro um eine regulierte Plattform handelt, müssen Sie das KYC-Verfahren abschließen. Dies ist gängige Praxis und dauert nur ein paar Minuten. Sie müssen einen Lichtbildausweis (Reisepass, Führerschein) und einen Adressnachweis (Stromrechnung, Kontoauszug) vorlegen.
Sobald Sie sich angemeldet und Ihr Konto verifiziert haben, müssen Sie Geld einzahlen. eToro akzeptiert Kredit-/Debitkarten, Banküberweisungen und auch E-Wallets. Was auch immer Sie bevorzugen, es wird etwas für Sie dabei sein.
Now that you’ve funded your eToro account, just type “AMEX:SYN stocks" in die Suchleiste am oberen Rand des Bildschirms ein und drücken Sie auf "Handeln".
All that’s left is to buy some AMEX:SYN stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, AMEX:SYN is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Synthetic Biologics stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Synthetic Biologics is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for Synthetic Biologics.
Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) released its quarterly earnings results on Tuesday, November, 10th. The company reported ($0.14) earnings per share (EPS) for the quarter.
View Synthetic Biologics’ earnings history.
Synthetic Biologics’ stock was trading at $0.36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SYN shares have increased by 155.6% and is now trading at $0.92.
Synthetic Biologics’s stock reverse split on the morning of Monday, August 13th 2018. The 1-35 reverse split was announced on Wednesday, August 1st 2018. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 10th 2018. An investor that had 100 shares of Synthetic Biologics stock prior to the reverse split would have 3 shares after the split.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:SYN stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mehr als 95% der Kundengelder werden offline, in kalten Lagern, aufbewahrt, was für jeden Broker, der Ihr Vermögen verwaltet, entscheidend ist. Unabhängig davon, wie sicher eine Plattform sein soll, empfehlen wir die Verwendung von 2FA, um eine zusätzliche Sicherheitsebene für Ihr Konto zu schaffen.
eToro bietet Nutzern eine Reihe von Funktionen, um so schnell wie möglich mit dem Investieren zu beginnen. Es gibt eine relativ einzigartige Funktion namens Copy Trading, mit der Sie ein passives Einkommen erzielen können, indem Sie erfahrene Händler spiegeln. So können Sie schnell Gewinne erzielen und erhalten ein besseres Verständnis für die Strategien, die von Profis verwendet werden. Außerdem können Sie bei eToro in verwaltete Portfolios investieren. Ein verwaltetes Portfolio besteht aus einer Vielzahl ähnlicher Vermögenswerte, die in Gruppen zusammengefasst sind. Wenn Sie bereits über Handelserfahrung verfügen, können Sie auch in andere Märkte als Aktien investieren, da eToro den Handel mit ETFs, Rohstoffen, Kryptowährungen und Indizes ermöglicht. Wenn Sie bereits außerhalb des Aktienmarktes investieren, kann dies sehr nützlich sein, da Sie so alle Ihre Investitionen an einem einzigen Ort verwalten können.
2 Wall Street analysts have issued 12 month target prices for Synthetic Biologics’ stock. Their forecasts range from $1.25 to $1.50. On average, they expect Synthetic Biologics’ stock price to reach $1.38 in the next twelve months. This suggests a possible upside of 49.5% from the stock’s current price.
View analysts’ price targets for Synthetic Biologics or view top-rated stocks among Wall Street analysts.
Synthetic Biologics saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 1,810,000 shares, an increase of 565.4% from the December 31st total of 272,000 shares. Based on an average trading volume of 11,400,000 shares, the days-to-cover ratio is currently 0.2 days.
View Synthetic Biologics’ Short Interest.
CFDs sind komplexe Instrumente und bergen aufgrund der Hebelwirkung ein hohes Risiko, schnell Geld zu verlieren. 68% der Konten von Kleinanlegern verlieren Geld beim Handel mit CFDs bei diesem Anbieter. Sie sollten sich überlegen, ob Sie verstehen, wie CFDs funktionieren und ob Sie das hohe Risiko, Ihr Geld zu verlieren, eingehen können.
Synthetic Biologics’ management team includes the following people:
Mr. Steven A. Shallcross CPA, CEO, CFO, Treasurer, Corp. Sec. & Director (Age 60, Pay $989.81k)
Vincent I. Perrone, Director of Corp. Communication
Dr. Vince Wacher, Head of Product and Corp. Devel.
Dr. Michael Kaleko, Sr. VP of R&D
Ms. Lara M. Guzman, Sr. Director of Project Operations
Some companies that are related to Synthetic Biologics include Aeterna Zentaris (AEZS), Elite Pharmaceuticals (ELTP), Vaccinex (VCNX), Mereo BioPharma Group (MREO), CannTrust (CNTTF), Catabasis Pharmaceuticals (CATB), CV Sciences (CVSI), Iterum Therapeutics (ITRM), Celsion (CLSN), Acerus Pharmaceuticals (ASPCF), Trevi Therapeutics (TRVI), CNS Pharmaceuticals (CNSP), Regulus Therapeutics (RGLS), Appili Therapeutics (APLIF) and Pulmatrix (PULM).
View all of SYN’s competitors.
Based on aggregate information from Reportlab, some companies that other Synthetic Biologics investors own include Synergy Pharmaceuticals (SGYP), Tonix Pharmaceuticals (TNXP), Agenus (AGEN), Palatin Technologies (PTN), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), CorMedix (CRMD), Idera Pharmaceuticals (IDRA), Ampio Pharmaceuticals (AMPE) and Navidea Biopharmaceuticals (NAVB).
Synthetic Biologics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “SYN.”
1 | | Minimale Einzahlung $50 Exklusive Aktion | Unser Ergebnis 10 ★★★★★ | 0% Kommission |
Synthetic Biologics’ stock is owned by a number of institutional and retail investors. Top institutional shareholders include Fisher Asset Management LLC (0.63%). Company insiders that own Synthetic Biologics stock include Randal J Kirk and Steven A Shallcross.
View institutional ownership trends for Synthetic Biologics.
SYN stock was acquired by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC.
View insider buying and selling activity for Synthetic Biologics or or view top insider-buying stocks.
Shares of SYN can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interaktive Makler Bewertung, eToro Überprüfung, DEGiro Rückblick, AvaTrade Bewertung, IG Markets Rückblick, IC Märkte Rückblick, CMC Markets Rückblick, Admiral Markets Rückblick und viele mehr. Lesen Sie eine der Bewertungen, um alles über den Broker zu erfahren, und beginnen Sie jetzt mit dem Kauf von Aktien.
One share of SYN stock can currently be purchased for approximately $0.92.
Synthetic Biologics has a market capitalization of $18.39 million.
Synthetic Biologics employs 11 workers across the globe.
Wir von Reportlab.org möchten sicherstellen, dass Sie alle wichtigen Informationen über Aktien kaufen. Wir bieten Ihnen die besten Leitfäden zum Thema Börse mit persönlichen Bewertungen, Hintergrundinformationen, Plattformbewertungen, Anleitungen und mehr. Möchten Sie weitere Informationen erhalten? Dann schauen Sie sich die OTC-Aktien, NASDAQ-Aktien, NYSE-Aktien, LON-Aktien, FRA-Aktien, ETR-Aktien, EPA-Bestände, TSX-Aktien oder Amex Aktien. Sie suchen nach detaillierteren Informationen wie 5g Vorräte, Biotech-Aktien, Goldvorräte und andere Informationen aus unserem Reportlab.
How can you buy Synthetic Biologics stock on the internet?
You can easily buy Synthetic Biologics stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Eine weitere Option ist die Nutzung eines regulierten Brokers wie IC-Märkte oder Interaktive Makler. You can an account with these brokers and start buying or trading AMEX:SYN stocks in a safe and complete environment to trade in.
Where to buy Synthetic Biologics stock?
You will first want to find a licensed broker that supports AMEX:SYN stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:SYN stocks in a safe and complete environment.
Is AMEX:SYN stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:SYN stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Synthetic Biologics stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:SYN is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Synthetic Biologics stock.
How do you trade Synthetic Biologics stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Synthetic Biologics stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:SYN stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Synthetic Biologics stock?
To sell your AMEX:SYN stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Synthetic Biologics stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:SYN stock.
Stephen kennt sich gut mit Finanzprodukten aus und hat insbesondere eine große Leidenschaft für die Aktienmärkte und ihre Teilnehmer. Wir hoffen, dass die bereitgestellten Informationen Ihnen helfen werden. Ist Ihnen etwas nicht ganz klar? Bitte hinterlassen Sie Ihre Fragen oder Kommentare unten auf der Seite.
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ | |
| Unser Ergebnis ★★★★★ |
Newsletter
Neueste Nachrichten
| |
Unser Ergebnis |
0% Kommission |
Top 10 5G Aktien Mehr Informationen 5G Aktien Top 10 Beste 5G Aktien zum Kaufen
Alle EPA-Aktien Weitere Informationen EPA-Aktien Was ist die Pariser Börse (EPA)? Jetzt
Aktien & Krypto-Daten in Echtzeit
Benachrichtigungen, Tipps & Neuigkeiten
Beste Aktien & Krypto-Führer
Online Broker & Börse Bewertungen
Reportlab Finanzen ist eine rein informative Website und stellt in keinem Fall eine Anlageberatung dar. Alle Investitionen sind mit Risiken verbunden und Sie können Ihre gesamten Investitionen verlieren. Investieren Sie kein Geld, das Sie sich nicht leisten können, zu verlieren.
Reportlab Finanzen
38 Holburn Lane
Heckfield Green
IP21 0UB
Vereinigtes Königreich
Copyright © 2022 Reportlab.Finance | Alle Rechte vorbehalten.
